A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies (Q71032334)
Jump to navigation
Jump to search
scientific article published on 01 January 1996
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies |
scientific article published on 01 January 1996 |
Statements
A phase I/II study of high-dose cyclophosphamide, cisplatin, and thioTEPA followed by autologous bone marrow and granulocyte colony-stimulating factor-primed peripheral-blood progenitor cells in patients with advanced malignancies (English)
E J Shpall
A M Hussein
W P Petros
M Ross
J J Vredenburgh
M L Affrontil
P Rubin
M Elkordy
C Gilbert
C Gupton
M J Egorin
J Soper
A Berchuck
D Clarke-Person
D A Berry